{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T02:08:12Z","timestamp":1649124492509},"reference-count":8,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Jpn. Soc. Intern. Med","J. Jpn. Soc. Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/naika.103.1388","type":"journal-article","created":{"date-parts":[[2015,6,9]],"date-time":"2015-06-09T22:05:43Z","timestamp":1433887543000},"page":"1388-1390","source":"Crossref","is-referenced-by-count":1,"title":["Fanconi's Syndrome and Hypophosphatemic Osteomalacia Associated with Adefovir Dipivoxil: A Case Report"],"prefix":"10.2169","volume":"103","author":[{"given":"Kazutoshi","family":"Hirose","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Nephrology Center, Toranomon Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Ubara","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nephrology Center, Toranomon Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikako","family":"Hiramatsu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nephrology Center, Toranomon Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Sawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nephrology Center, Toranomon Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiko","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nephrology Center, Toranomon Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenmei","family":"Takaichi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Nephrology Center, Toranomon Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Kumada","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Toranomon Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoaki","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Toranomon Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"2) Izzedine H, et al: Antiviral drug-induced nephrotoxicity. American Journal of Kidney Diseases 45: 804-817, 2005.","DOI":"10.1053\/j.ajkd.2005.02.010"},{"key":"2","doi-asserted-by":"crossref","unstructured":"3) Tanaka M, et al: Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B. J Gastroenterol: 26 March 2013.","DOI":"10.1007\/s00535-013-0779-0"},{"key":"3","doi-asserted-by":"publisher","unstructured":"4) Dai CL, et al: Prolonged adefovir therapy associated Fanconi syndrome and interstitial nephritis in hepatitis B. Internal Medicine Journal 42: 955-957, 2012.","DOI":"10.1111\/j.1445-5994.2012.02854.x"},{"key":"4","doi-asserted-by":"publisher","unstructured":"5) Law ST, et al: Nephrotoxicity, including acquired Fanconi's syndrome, caused by adefovir dipivoxil-is there a safe dose? Journal of Clinical Pharmacy and Therapeutics 37: 128-131, 2012.","DOI":"10.1111\/j.1365-2710.2011.01278.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6) Jung YK, et al: Fanconi's syndrome associated with prolonged adefovir dipivoxil therapy in a hepatitis B virus patient. Gut Liver 4: 389-393, 2010.","DOI":"10.5009\/gnl.2010.4.3.389"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7) Kim du H, et al: Hypophosphatemic osteomalacia induced by low-dose adefovir therapy: focus on manifestations in the skeletal system and literature review. J Bone Miner Metab 31: 240-246, 2013.","DOI":"10.1007\/s00774-012-0384-y"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8) Cihlar T, et al: Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs. Nucleos Nucleot Nucleic Acids 20: 641-648, 2001.","DOI":"10.1081\/NCN-100002341"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9) Vigano M, et al: A drug transporter gene polymorphism predicts renal tubular toxicity in patients with chronic hepatitis B on long-term adefovir and lamivudine combination. J Hepatol 52: S7, 2010.","DOI":"10.1016\/S0168-8278(10)60016-5"}],"container-title":["Nihon Naika Gakkai Zasshi"],"original-title":["\u6297B\u578b\u809d\u708e\u30a6\u30a4\u30eb\u30b9\u85ac\u306e\u30a2\u30c7\u30d5\u30a9\u30d3\u30eb\u306b\u3088\u308a\u85ac\u5264\u6027Fanconi\u75c7\u5019\u7fa4\u304a\u3088\u3073\u4f4eP\u8840\u75c7\u6027\u9aa8\u8edf\u5316\u75c7\u3092\u304d\u305f\u3057\u305f1\u4f8b"],"language":"en","deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T12:00:16Z","timestamp":1566820816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/103\/6\/103_1388\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/naika.103.1388","relation":{},"ISSN":["0021-5384","1883-2083"],"issn-type":[{"value":"0021-5384","type":"print"},{"value":"1883-2083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}